Bone Cement & Glue Market by Bone Cement (PMMA, Calcium Phosphate), Bone Glue (Natural, Synthetic), Loading (Antibiotic Loaded), Application (Arthroplasty, Kyphoplasty, Vertebroplasty), End User (Hospitals, ASCS, Clinics) & Region - Global Forecast to 2028

Abstract
The global Bone Cement & Glue Market is projected to reach USD 2,248 million by 2028 from USD 1,644 million in 2023, at a CAGR of 6.5% during the forecast period. The growth of this market is majorly driven by Increasing number of bone fractures and surgeries and Strategic Collaborations and Partnerships. However, Challenges associated with cost and affordability may threat the growth of this market.

“Total knee arthroplasty in the type of segment to witness the highest growth during the forecast period.”

Based on the Type, the arthroplasty market is segmented into Total knee arthroplasty, Total hip arthroplasty
Total shoulder arthroplasty. Total knee arthroplasty is projected to grow at the highest CAGR during the forecast period. The significant factors contributing to the growth of this market is The increasing prevalence of knee osteoarthritis and the aging population have contributed to a growing number of TKA procedures worldwide which drives the bone glue and cement market.

“Europe is estimated to register the third highest CAGR during the forecast period.”

In this report, the Bone cement & glue market is segmented into four major regional segments: North America, Europe, Asia Pacific, Rest of the world. The market in Europe is projected to register the third highest growth rate during the forecast period. The growth in this market is primarily driven by the presence of significant aging population, with a higher proportion of individuals aged 65 and above. The aging demographic is more prone to orthopedic conditions, such as osteoarthritis and fractures, which often require surgical interventions using bone cement and glue, High Prevalence of Orthopedic Conditions, Growing Number of Orthopedic Surgeries, and Technological Advancements in healthcare sectors.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (48%), Tier 2 (34%), and Tier 3 (18%)
• By Designation: C-level (33%), Director-level (40%), and Others (27%)
• By Region: North America (36%), Europe (28%), AsiaPacific (20%), Rest of the World (16%)

List of Companies Profiled in the Report
Stryker (US)
 Zimmer Biomet (US)
DePuy Synthes (a subsidiary of Johnson & Johnson - US)
Smith+Nephew.(UK)
Arthrex, Inc. (US)
Enovis (US)
Globus Medical (US)
Exactech, Inc.(US)
Heraeus Holding (Germany)
Artivion, Inc (US)
Cardinal Health. (US)
Teknimed (France)
Medtronic (Ireland)
Tecres S.p.A.(Italy)
Bioceramed, S.A. (Portugal)
Evolutis (France)
Normmed Medical (Turkey)
LINACOL Medical (Turkey)
BPB MEDICA (Italy)
 IZI Medical (US)
Aditus Medical. (Germany)
OSARTIS GmbH (Germany)
LD Davis (US)
Milligan & Higgins (US)
VHERN srl (US)

Research Coverage:
This report studies the Bone cement & glue market based on product and region. The report also analyzes factors (such as drivers, opportunities, and challenges, restraints) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total Bone cement & glue market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
•Market Penetration: Comprehensive information on bio decontamination products offered by the top 25 players in the Bone cement & glue market. The report analyzes the Bone cement & glue market by Type, and region.
•Market Drivers: Comprehensive information about the factors and conditions that stimulate and influence the growth and performance of a specific market.
•Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
•Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the Bone cement & glue market.
•Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the Bone cement & glue market.

Content
Table of Contents

1INTRODUCTION23
1.1STUDY OBJECTIVES23
1.2MARKET DEFINITION23
1.2.1INCLUSIONS AND EXCLUSIONS23
1.3MARKET SCOPE24
1.3.1MARKETS COVERED24
1.3.2REGIONS COVERED24
1.3.3YEARS CONSIDERED25
1.3.4CURRENCY CONSIDERED25
1.4LIMITATIONS25
1.5STAKEHOLDERS26
1.6RECESSION IMPACT26
2RESEARCH METHODOLOGY27
FIGURE 1RESEARCH DESIGN27
2.1RESEARCH DATA28
2.1.1SECONDARY DATA28
2.1.1.1Key data from secondary sources28
2.1.2PRIMARY DATA29
FIGURE 2PRIMARY SOURCES29
2.1.2.1Breakdown of primary interviews30
2.1.2.2Key data from primary sources31
2.2MARKET SIZE ESTIMATION32
FIGURE 3MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH32
FIGURE 4BOTTOM-UP APPROACH: PROCEDURE-BASED ANALYSIS33
2.2.1GROWTH FORECAST33
FIGURE 5CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS34
FIGURE 6TOP-DOWN APPROACH34
2.3MARKET BREAKDOWN AND DATA TRIANGULATION35
FIGURE 7DATA TRIANGULATION METHODOLOGY35
2.4ASSUMPTIONS36
2.5RECESSION IMPACT ANALYSIS36
3EXECUTIVE SUMMARY37
FIGURE 8BONE CEMENT & GLUE MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)37
FIGURE 9BONE CEMENT & GLUE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)38
FIGURE 10BONE CEMENT & GLUE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)38
FIGURE 11BONE CEMENT & GLUE MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)39
4PREMIUM INSIGHTS40
4.1ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BONE CEMENT & GLUE MARKET40
FIGURE 12GROWING GERIATRIC POPULATION TO DRIVE MARKET40
4.2BONE CEMENT MARKET, BY TYPE41
FIGURE 13PMMA CEMENT TO REGISTER HIGHER GROWTH OVER FORECAST PERIOD41
4.3NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY TYPE AND COUNTRY42
FIGURE 14US ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 202242
4.4BONE CEMENT & GLUE MARKET, BY COUNTRY43
FIGURE 15INDIA AND CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD43
5MARKET OVERVIEW44
5.1INTRODUCTION44
5.2MARKET DYNAMICS44
FIGURE 16BONE CEMENT & GLUE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES44
5.2.1DRIVERS45
5.2.1.1Growing incidence of sports injuries45
5.2.1.2Rapid growth in geriatric population45
TABLE 1GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050 (MILLION)46
5.2.1.3Developments in regenerative medicine47
5.2.1.4Growing number of road traffic accidents and other factors increasing surgery volumes48
5.2.1.5Technological advancements48
5.2.2RESTRAINTS49
5.2.2.1High costs and extensive clinical data requirements for launching new products49
5.2.2.2Alternatives to bone cement and glue50
5.2.3OPPORTUNITIES51
5.2.3.1Growth opportunities in emerging economies51
5.2.3.2Rising awareness and demand for minimally invasive procedures51
5.2.4CHALLENGES52
5.2.4.1Development of novel biomaterials with high mechanical properties and adhesion strength52
5.2.4.2Product-related complications52
5.2.4.3Unfavorable reimbursement scenario53
6BONE CEMENT & GLUE MARKET, BY TYPE55
6.1INTRODUCTION56
TABLE 2BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)56
6.2BONE CEMENT56
TABLE 3CONSTITUENTS OF BONE CEMENT57
TABLE 4BONE CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION)57
6.2.1BONE CEMENT MARKET, BY TYPE57
TABLE 5BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)58
6.2.1.1PMMA cement58
6.2.1.1.1Wide usage and properties of PMMA to drive market58
TABLE 6PMMA CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION)58
6.2.1.2Calcium phosphate cement59
6.2.1.2.1High biocompatibility and radiopacity to drive adoption59
TABLE 7CPC MARKET, BY REGION, 2021–2028 (USD MILLION)59
6.2.1.3Glass polyalkenoate cement59
6.2.1.3.1Wide applications in dentistry to drive market59
TABLE 8GPC MARKET, BY REGION, 2021–2028 (USD MILLION)60
6.2.2BONE CEMENT MARKET, BY LOADING60
TABLE 9BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)60
6.2.2.1Antibiotic-loaded bone cement61
6.2.2.1.1High risk of developing deep infections during surgeries to support adoption61
TABLE 10ANTIBIOTIC-LOADED BONE CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION)61
6.2.2.2Non-antibiotic-loaded bone cement61
6.2.2.2.1Low cost and less-stringent regulations to support usage61
TABLE 11NON-ANTIBIOTIC-LOADED BONE CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION)62
6.3BONE GLUE62
TABLE 12BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)63
TABLE 13BONE GLUE MARKET, BY REGION, 2021–2028 (USD MILLION)63
6.3.1NATURAL BONE GLUE63
6.3.1.1High biocompatibility to support greater adoption63
TABLE 14NATURAL BONE GLUE MARKET, BY REGION, 2021–2028 (USD MILLION)64
6.3.2SYNTHETIC BONE GLUE64
6.3.2.1Emerging medical applications indicate high potential of synthetic glue64
TABLE 15SYNTHETIC BONE GLUE MARKET, BY REGION, 2021–2028 (USD MILLION)64
7BONE CEMENT & GLUE MARKET, BY APPLICATION65
7.1INTRODUCTION66
TABLE 16BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)66
7.2ARTHROPLASTY66
TABLE 17BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION)67
TABLE 18BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)67
7.2.1TOTAL KNEE ARTHROPLASTY67
7.2.1.1TKA to hold largest arthroplasty market share67
TABLE 19BONE CEMENT & GLUE MARKET FOR TOTAL KNEE ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION)68
7.2.2TOTAL HIP ARTHROPLASTY68
7.2.2.1Growing geriatric population to boost procedural volumes68
TABLE 20BONE CEMENT & GLUE MARKET FOR TOTAL HIP ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION)69
7.2.3TOTAL SHOULDER ARTHROPLASTY69
7.2.3.1Rising sports injury incidence to drive market69
TABLE 21BONE CEMENT & GLUE MARKET FOR TOTAL SHOULDER ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION)70
7.3KYPHOPLASTY70
7.3.1INCREASING INCIDENCE OF OSTEOPOROSIS TO DRIVE MARKET70
TABLE 22TOP TEN COUNTRIES IN KYPHOPLASTY RESEARCH71
TABLE 23BONE CEMENT & GLUE MARKET FOR KYPHOPLASTY, BY REGION, 2021–2028 (USD MILLION)71
7.4VERTEBROPLASTY71
7.4.1RISING INCIDENCE OF VERTEBRAL COMPRESSION FRACTURES TO SUPPORT MARKET GROWTH71
TABLE 24BONE CEMENT & GLUE MARKET FOR VERTEBROPLASTY, BY REGION, 2021–2028 (USD MILLION)72
7.5OTHER APPLICATIONS72
TABLE 25BONE CEMENT & GLUE MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)73
8BONE CEMENT & GLUE MARKET, BY END USER74
8.1INTRODUCTION75
TABLE 26BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)75
8.2HOSPITALS & ASCS75
8.2.1HOSPITALS & ASCS TO DOMINATE END-USER MARKET75
TABLE 27BONE CEMENT & GLUE MARKET FOR HOSPITALS & ASCS, BY REGION, 2021–2028 (USD MILLION)76
8.3CLINICS & PHYSICIAN OFFICES76
8.3.1RISING PREFERENCE FOR CLINICS AND COST-SAVING POTENTIAL TO DRIVE MARKET76
TABLE 28BONE CEMENT & GLUE MARKET FOR CLINICS & PHYSICIAN OFFICES, BY REGION, 2021–2028 (USD MILLION)77
9BONE CEMENT & GLUE MARKET, BY REGION78
9.1INTRODUCTION79
TABLE 29BONE CEMENT & GLUE MARKET, BY REGION, 2021–2028 (USD MILLION)79
9.2NORTH AMERICA80
9.2.1NORTH AMERICA: RECESSION IMPACT80
FIGURE 17NORTH AMERICA: BONE CEMENT & GLUE MARKET SNAPSHOT81
TABLE 30NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)82
TABLE 31NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)82
TABLE 32NORTH AMERICA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)82
TABLE 33NORTH AMERICA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)83
TABLE 34NORTH AMERICA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)83
TABLE 35NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)83
TABLE 36NORTH AMERICA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)84
TABLE 37NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)84
9.2.2US84
9.2.2.1Growing geriatric population and high prevalence of sports injuries to drive market84
FIGURE 18TOTAL ESTIMATED INJURIES BY SPORTS ACTIVITY IN 202185
TABLE 38US: KEY MACROINDICATORS86
TABLE 39US: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)86
TABLE 40US: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)86
TABLE 41US: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)87
TABLE 42US: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)87
TABLE 43US: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)87
TABLE 44US: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)88
TABLE 45US: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)88
9.2.3CANADA89
9.2.3.1Availability of government funding and growth in geriatric population to drive market89
TABLE 46FUNDS FOR SPORTS ORGANIZATIONS, 2021/2022 (USD THOUSAND)89
TABLE 47CANADA: KEY MACROINDICATORS89
TABLE 48CANADA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)90
TABLE 49CANADA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)90
TABLE 50CANADA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)90
TABLE 51CANADA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)91
TABLE 52CANADA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)91
TABLE 53CANADA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)91
TABLE 54CANADA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)92
9.3EUROPE92
TABLE 55EUROPE: BURDEN OF OSTEOPOROSIS (2021)92
9.3.1EUROPE: RECESSION IMPACT93
TABLE 56EUROPE: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)93
TABLE 57EUROPE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)93
TABLE 58EUROPE: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)94
TABLE 59EUROPE: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)94
TABLE 60EUROPE: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)94
TABLE 61EUROPE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)95
TABLE 62EUROPE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)95
TABLE 63EUROPE: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)95
9.3.2FRANCE96
9.3.2.1Rising government support to drive demand96
TABLE 64FRANCE: KEY MACROINDICATORS96
TABLE 65FRANCE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)96
TABLE 66FRANCE: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)97
TABLE 67FRANCE: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)97
TABLE 68FRANCE: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)97
TABLE 69FRANCE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)98
TABLE 70FRANCE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)98
TABLE 71FRANCE: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)98
9.3.3GERMANY99
9.3.3.1Robust healthcare spending and advanced healthcare system to favor market growth99
TABLE 72GERMANY: KEY MACROINDICATORS99
TABLE 73GERMANY: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)100
TABLE 74GERMANY: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)100
TABLE 75GERMANY: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)100
TABLE 76GERMANY: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)101
TABLE 77GERMANY: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)101
TABLE 78GERMANY: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)101
TABLE 79GERMANY: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)102
9.3.4UK102
9.3.4.1Presence of strong healthcare infrastructure and high burden of orthopedic cases102
TABLE 80UK: KEY MACROINDICATORS103
TABLE 81UK: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)103
TABLE 82UK: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)103
TABLE 83UK: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)104
TABLE 84UK: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)104
TABLE 85UK: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)104
TABLE 86UK: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)105
TABLE 87UK: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)105
9.3.5REST OF EUROPE105
TABLE 88REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2021 (% OF GDP)106
TABLE 89REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)106
TABLE 90REST OF EUROPE: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)107
TABLE 91REST OF EUROPE: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)107
TABLE 92REST OF EUROPE: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)107
TABLE 93REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)108
TABLE 94REST OF EUROPE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)108
TABLE 95REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)109
9.4ASIA PACIFIC109
9.4.1ASIA PACIFIC: RECESSION IMPACT109
FIGURE 19ASIA PACIFIC: BONE CEMENT & GLUE MARKET SNAPSHOT110
TABLE 96ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION)111
TABLE 97ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)111
TABLE 98ASIA PACIFIC: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)111
TABLE 99ASIA PACIFIC: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)112
TABLE 100ASIA PACIFIC: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)112
TABLE 101ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)112
TABLE 102ASIA PACIFIC: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)113
TABLE 103ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)113
9.4.2CHINA113
9.4.2.1China to hold largest market share in APAC113
TABLE 104CHINA: KEY MACROINDICATORS114
TABLE 105INCIDENCE OF OSTEOPOROTIC FRACTURES IN CHINA, 2015–2035114
TABLE 106CHINA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)114
TABLE 107CHINA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)115
TABLE 108CHINA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)115
TABLE 109CHINA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)115
TABLE 110CHINA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)116
TABLE 111CHINA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)116
TABLE 112CHINA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)116
9.4.3INDIA117
9.4.3.1Rising medical tourism, improving healthcare infrastructure, and growing population to drive market117
TABLE 113INDIA: KEY MACROINDICATORS117
TABLE 114INDIA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)117
TABLE 115INDIA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)118
TABLE 116INDIA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)118
TABLE 117INDIA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)118
TABLE 118INDIA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)119
TABLE 119INDIA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)119
TABLE 120INDIA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)119
9.4.4JAPAN120
9.4.4.1Large aging population and favorable government initiatives to drive market120
TABLE 121JAPAN: KEY MACROINDICATORS120
TABLE 122JAPAN: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)120
TABLE 123JAPAN: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)121
TABLE 124JAPAN: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)121
TABLE 125JAPAN: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)121
TABLE 126JAPAN: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)122
TABLE 127JAPAN: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)122
TABLE 128JAPAN: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)122
9.4.5REST OF ASIA PACIFIC123
TABLE 129REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)123
TABLE 130REST OF ASIA PACIFIC: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)124
TABLE 131REST OF ASIA PACIFIC: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)124
TABLE 132REST OF ASIA PACIFIC: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)124
TABLE 133REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)125
TABLE 134REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)125
TABLE 135REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)126
9.5REST OF THE WORLD126
TABLE 136US VS. MEXICO: AVERAGE COST COMPARISON (USD)127
9.5.1ROW: RECESSION IMPACT127
TABLE 137REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)127
TABLE 138REST OF THE WORLD: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)128
TABLE 139REST OF THE WORLD: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION)128
TABLE 140REST OF THE WORLD: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION)128
TABLE 141REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)129
TABLE 142REST OF THE WORLD: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION)129
TABLE 143REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION)130
10COMPETITIVE LANDSCAPE131
10.1OVERVIEW131
10.2KEY PLAYER STRATEGIES/RIGHT TO WIN131
TABLE 144OVERVIEW OF STRATEGIES ADOPTED BY KEY BONE CEMENT & GLUE MARKET PLAYERS131
10.3MARKET SHARE ANALYSIS, 2022132
FIGURE 20BONE CEMENT & GLUE MARKET SHARE ANALYSIS, 2022132
TABLE 145BONE CEMENT & GLUE MARKET: DEGREE OF COMPETITION (2022)132
10.4REVENUE SHARE ANALYSIS, 2022133
FIGURE 21REVENUE ANALYSIS OF TOP FOUR MARKET PLAYERS (USD MILLION)133
10.5COMPANY EVALUATION MATRIX, 2022134
10.5.1STARS134
10.5.2EMERGING LEADERS134
10.5.3PERVASIVE PLAYERS134
10.5.4PARTICIPANTS134
FIGURE 22BONE CEMENT & GLUE MARKET: COMPANY EVALUATION MATRIX (2022)135
10.6COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022135
10.6.1PROGRESSIVE COMPANIES135
10.6.2STARTING BLOCKS136
10.6.3RESPONSIVE COMPANIES136
10.6.4DYNAMIC COMPANIES136
FIGURE 23BONE CEMENT & GLUE MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)136
10.7COMPETITIVE BENCHMARKING137
TABLE 146BONE CEMENT & GLUE MARKET: DETAILED LIST OF KEY SMES/STARTUPS137
10.8COMPANY FOOTPRINT ANALYSIS137
TABLE 147COMPANY FOOTPRINT ANALYSIS137
TABLE 148COMPANY PRODUCT FOOTPRINT138
TABLE 149COMPANY REGIONAL FOOTPRINT139
10.9COMPETITIVE SCENARIO140
10.9.1DEALS140
TABLE 150DEALS140
10.9.2OTHER DEVELOPMENTS141
TABLE 151OTHER DEVELOPMENTS141
11COMPANY PROFILES142
11.1KEY PLAYERS142
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1STRYKER142
TABLE 152STRYKER: BUSINESS OVERVIEW142
FIGURE 24STRYKER: COMPANY SNAPSHOT (2022)143
11.1.2ZIMMER BIOMET146
TABLE 153ZIMMER BIOMET: BUSINESS OVERVIEW146
FIGURE 25ZIMMER BIOMET: COMPANY SNAPSHOT (2022)147
11.1.3HERAEUS HOLDING149
TABLE 154HERAEUS HOLDING: BUSINESS OVERVIEW149
11.1.4SMITH+NEPHEW151
TABLE 155SMITH+NEPHEW: BUSINESS OVERVIEW151
FIGURE 26SMITH & NEPHEW: COMPANY SNAPSHOT (2022)152
11.1.5DEPUY SYNTHES (JOHNSON & JOHNSON)154
TABLE 156JOHNSON & JOHNSON: BUSINESS OVERVIEW154
FIGURE 27JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)155
11.1.6ENOVIS157
TABLE 157ENOVIS: BUSINESS OVERVIEW157
FIGURE 28ENOVIS: COMPANY SNAPSHOT (2022)157
11.1.7ARTIVION, INC.159
TABLE 158ARTIVION, INC.: BUSINESS OVERVIEW159
FIGURE 29ARTIVION, INC.: COMPANY SNAPSHOT (2022)160
11.1.8CARDINAL HEALTH161
TABLE 159CARDINAL HEALTH: BUSINESS OVERVIEW161
FIGURE 30CARDINAL HEALTH.: COMPANY SNAPSHOT (2022)162
11.1.9MEDTRONIC163
TABLE 160MEDTRONIC: BUSINESS OVERVIEW163
FIGURE 31MEDTRONIC: COMPANY SNAPSHOT (2022)164
11.1.10GLOBUS MEDICAL165
TABLE 161GLOBUS MEDICAL: BUSINESS OVERVIEW165
FIGURE 32GLOBUS MEDICAL: COMPANY SNAPSHOT (2022)166
11.1.11EXACTECH, INC.168
TABLE 162EXACTECH, INC.: BUSINESS OVERVIEW168
11.1.12ARTHREX, INC.169
TABLE 163ARTHREX, INC.: BUSINESS OVERVIEW169
11.1.13TEKNIMED170
TABLE 164TEKNIMED: BUSINESS OVERVIEW170
11.1.14TECRES S.P.A.171
TABLE 165TECRES S.P.A.: BUSINESS OVERVIEW171
11.1.15BIOCERAMED S.A.172
TABLE 166BIOCERAMED, S.A.: BUSINESS OVERVIEW172
11.1.16EVOLUTIS173
TABLE 167EVOLUTIS: BUSINESS OVERVIEW173
11.2OTHER PLAYERS174
11.2.1NORMMED MEDICAL174
11.2.2LINACOL MEDICAL INC.174
11.2.3BPB MEDICA175
11.2.4IZI MEDICAL175
11.2.5ADITUS MEDICAL176
11.2.6OSARTIS GMBH176
11.2.7LD DAVIS177
11.2.8MILLIGAN & HIGGINS177
11.2.9VHERN S.R.L.178
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12APPENDIX179
12.1INDUSTRY INSIGHTS179
12.2DISCUSSION GUIDE180
12.3KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL184
12.4CUSTOMIZATION OPTIONS186
12.5RELATED REPORTS187
12.6AUTHOR DETAILS188